Dr Westin on Early Findings With Azenosertib in High-Grade Serous Ovarian Cancer

Shannon N. Westin, MD, MPH, FACOG, discusses the DENALI trial of azenosertib
in patients with high-grade serous ovarian cancer.

Related Keywords

Texas ,United States ,Shannonn Westin , ,Division Of Surgery ,University Of Texas Md Anderson Cancer Center ,Department Of Gynecologic Oncology ,Early Drug Development ,Ovarian Cancer Moonshot Program ,Gynecologic Oncology ,Reproductive Medicine ,Cancer Center ,D ,Bph ,Iacog ,Denali Trial ,Azenosertib ,Patients With High Grade Serous Ovarian Cancer ,